Sara Froelich, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: N 10 River Rd, Fort Yates, ND 58538 Phone: 701-854-3831 Fax: 701-854-8380 |
Kimberly Hawk Eagle, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 10 N River Road, Fort Yates, ND 58538 Phone: 701-854-3831 |
Aurelia R Snider, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: N10 North River Road, Fort Yates, ND 58538 Phone: 701-854-3831 Fax: 701-854-3685 |
Xtal Silk, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 10 N River Road, Fort Yates, ND 58538 Phone: 701-854-3831 |
Donna Sue Luger, RN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: N10 North River Road, Fort Yates, ND 58538 Phone: 701-854-3831 Fax: 701-854-3685 |
News Archive
Much anticipated knockoff versions of costly biotech medicines are facing delays and obstacles that could cost patients and health systems billions in missed savings.
ZymoGenetics, Inc., today announced the publication of pooled safety and immunogenicity observations from eight clinical trials of RECOTHROM in the February issue of the Journal of the American College of Surgeons. The authors concluded that RECOTHROM is a well-tolerated topical hemostatic agent in numerous surgical settings and has a low rate of anti-product antibody formation. In the pooled data from all trials, less than one percent of treated patients developed product-specific antibodies. None of the antibodies neutralized native coagulation proteins.
In a departure from other industry polls, employers said they plan to reject private exchanges as a way to control rising health care costs, according to a new survey of more than 330 employers conducted by the non-profit National Business Coalition on Health and Benz Communications.
Karius, a life sciences company transforming infectious disease diagnostics with genomics and data through the innovative use of next-generation sequencing to analyze microbial cell-free DNA, announced today the positive results of a clinical study using blood samples from patients with confirmed invasive fungal infections.
A recent study reveals that the genetic variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) detected in the initial phase of coronavirus disease 2019 (COVID-19) pandemic differ from the variants detected in a massive second wave of infection in Houston, Texas. The study is currently available on the medRxiv preprint server.
› Verified 7 days ago